HOME >> BIOLOGY >> NEWS
Control of fat cell development demonstrated using Sangamo BioSciences' ZFP technology

In vivo studies on function of gene variant critical to development of fat cells conducted in collaboration with Pfizer scientists

Richmond, California December 31, 2001 Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced the publication of results using its engineered zinc finger DNA-binding proteins (ZFPs) to repress expression of a gene required for the development of fat cells (adipogenesis). The paper is being published in the January 1, 2002 issue of the journal Genes & Development and is co-authored by scientists from Pfizer Inc (NYSE: PFE) and Sangamo.

The data presented in the paper represent a significant advance in the external application and validation of Sangamos ZFP transcription factor (ZFP-TF) technology, which enables the specific control of genes within an organism. Sangamo ZFP-TFs specifically repressed expression of a gene variant, or isoform, in a mouse cell type that is the precursor to fat cells. Repression of the gene prevented the cells from developing into mature fat cells (adipocytes).

This initial finding led the scientists to further study the role of the gene, known as PPARgamma, in the development of fat cells. In particular, through the use of two ZFP-TFs that bind at slightly different positions on the gene, the scientists for the first time precisely identified the PPARgamma2 isoform as the gene variant critical for fat cell development.

In a commentary published in the same issue of Genes & Development, Mitchell A. Lazar, M.D., Ph.D., Professor of Medicine and Genetics, Chief, Division of Endocrinology, Diabetes and Metabolism and Director, Penn Diabetes Center of the University of Pennsylvania School of Medicine, said, ". . . [T]he relative importance of the two PPARgamma isoforms for adipogenesis has remained an open question because PPARgamma1 and PPARgamma2 are expressed at comparable levels in adipocytes. Ren and coworkers have elegantly addressed this question." Dr. De
'"/>

Contact: Carol DeGuzman
cdeguzman@sangamo.com
510-970-6000 x256
Eukarion, Inc
31-Dec-2001


Page: 1 2

Related biology news :

1. Controlling biomolecules with magnetic tweezers
2. Controlling the internal clock in darkness
3. Controlling body size by regulating the number of cells
4. Controlling cell adhesion: Researchers report first evidence of catch bonds
5. Control of intestinal inflammation by PGE2 and its receptor
6. Controlled nerve growth factor aids brain cell transplant
7. Controlling greenhouse gas carbon dioxide through carbon sequestration two-day symposium, April 2-3
8. New Gene Holds Promise For Controlling Crohns And Other Inflammatory Diseases
9. Researchers Discover Fast Efficient, Controllable Way To Study Molecular Interactions
10. Discovery Of A Molecule That Controls Bile Acids May Lead To New Cholesterol Drugs
11. Dual Control Strategy Assures Accurate Cellular Marching Orders, But A Pathogenic Microbe Can Hijack The System

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2020)... ... February 06, 2020 , ... Syntactx, ... device and pharmaceutical trials, announced that Ms. Dorothy Abel has joined the ... oversees the development and execution of regulatory plans designed to help clients ...
(Date:2/1/2020)... ... 01, 2020 , ... Liver cancer, called hepatocellular carcinoma (HCC), occurs each year ... disease. HCC is the 5th most common cancer and the 2nd leading cause of ... to incidence of HCC, while China has half of all patients suffering from liver ...
(Date:1/29/2020)... ... January 29, 2020 , ... ... it will start production of a DNA vaccine against the novel coronavirus (2019-nCoV) ... Pharmaceuticals. A grant of up to $9 million from the Coalition for Epidemic ...
Breaking Biology News(10 mins):
(Date:1/24/2020)... ... January 24, 2020 , ... The impact of new medicines, ... laboratory and clinical services during the first two decades of the 21st century ... Slone Partners celebrates its 20th anniversary this year, its evolution as ...
(Date:1/22/2020)... FRANKLIN, Wis. (PRWEB) , ... January 21, 2020 ... ... announce the hiring of Darrell Taylor as Southern Midwest Region Industrial and Institutional ... to the SporActiv™ product line. , Darrell brings over 30 years ...
(Date:1/10/2020)... ... January 09, 2020 , ... ... services, today announced the acquisition of Cunesoft, a move that expands the company’s ... objectives of life sciences companies. , Based in Munich, Germany, Cunesoft provides intelligent ...
(Date:1/7/2020)... ... January 07, 2020 , ... Absolute Antibody Ltd. ... launch of its VivopureX™ recombinant mouse antibodies for in vivo research in mouse ... or hamsters, which Absolute Antibody has engineered into mouse-anti-mouse recombinant versions to improve ...
Breaking Biology Technology:
Cached News: